{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:25:51Z","timestamp":1791876351078,"version":"4.3.4"},"publisher-location":"Berlin, Heidelberg","reference-count":114,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642389641","type":"print"},{"value":"9783642389658","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-642-38965-8_14","type":"book-chapter","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T14:16:18Z","timestamp":1378390578000},"page":"269-290","source":"Crossref","is-referenced-by-count":12,"title":["Anti-Viral Treatment and Cancer Control"],"prefix":"10.1007","author":[{"given":"Wei-Liang","family":"Shih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Tai","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jer","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,6]]},"reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","volume":"28","author":"A Bazarbachi","year":"2010","unstructured":"Bazarbachi A, Plumelle Y, Carlos Ramos J, Tortevoye P, Otrock Z, Taylor G, Gessain A, Harrington W, Panelatti G, Hermine O (2010) Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol 28:4177\u20134183","journal-title":"J Clin Oncol"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-1-61779-188-8_21","volume":"764","author":"ML Benitez-Hess","year":"2011","unstructured":"Benitez-Hess ML, Reyes-Gutierrez P, Alvarez-Salas LM (2011) Inhibition of human papillomavirus expression using DNAzymes. Methods Mol Biol 764:317\u2013335","journal-title":"Methods Mol Biol"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1586\/erv.09.145","volume":"9","author":"LG Berm\u00fadez-Humar\u00e1n","year":"2010","unstructured":"Berm\u00fadez-Humar\u00e1n LG, Langella P (2010) Perspectives for the development of human papillomavirus vaccines and immunotherapy. Expert Rev Vaccines 9:35\u201344","journal-title":"Expert Rev Vaccines"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1080\/1042819021000039983","volume":"43","author":"C Besson","year":"2002","unstructured":"Besson C, Panelatti G, Delaunay C, Gonin C, Brebion A, Hermine O, Plumelle Y (2002) Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide. Leuk Lymphoma 43:2275\u20132279","journal-title":"Leuk Lymphoma"},{"key":"14_CR5","first-page":"296","volume":"130","author":"AC Bharti","year":"2009","unstructured":"Bharti AC, Shukla S, Mahata S, Hedau S, Das BC (2009) Anti-human papillomavirus therapeutics: facts & future. Indian J Med Res 130:296\u2013310","journal-title":"Indian J Med Res"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/0284186X.2010.512924","volume":"50","author":"C Biver-Dalle","year":"2011","unstructured":"Biver-Dalle C, Nguyen T, Touze A, Saccomani C, Penz S, Cunat-Peultier S, Riou-Gotta MO, Humbert P, Coursaget P, Aubin F (2011) Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus. Acta Oncol 50:479\u2013480","journal-title":"Acta Oncol"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1084\/jem.20040890","volume":"200","author":"CM Bollard","year":"2004","unstructured":"Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Rousseau A, Sixbey J, Gresik MV, Carrum G, Hudson M, Dilloo D, Gee A, Brenner MK, Rooney CM, Heslop HE (2004) Cytotoxic T lymphocyte therapy for Epstein-Barr virus+\u00a0Hodgkin\u2019s disease. J Exp Med 200:1623\u20131633","journal-title":"J Exp Med"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1158\/1055-9965.EPI-07-2865","volume":"17","author":"GA Boulet","year":"2008","unstructured":"Boulet GA, Horvath CA, Berghmans S, Bogers J (2008) Human papillomavirus in cervical cancer screening: important role as biomarker. Cancer Epidemiol Biomarkers Prev 17:810\u2013817","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00002030-200402200-00015","volume":"18","author":"D Bourboulia","year":"2004","unstructured":"Bourboulia D, Aldam D, Lagos D, Allen E, Williams I, Cornforth D, Copas A (2004) Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS 18:485\u2013493","journal-title":"AIDS"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/01.qco.0000200295.30285.13","volume":"19","author":"M Bower","year":"2006","unstructured":"Bower M, Palmieri C, Dhillon T (2006) AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 19:14\u201319","journal-title":"Curr Opin Infect Dis"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1155\/2007\/245146","volume":"23","author":"JA Brinkman","year":"2007","unstructured":"Brinkman JA, Hughes SH, Stone P, Caffrey AS, Muderspach LI, Roman LD, Weber JS, Kast WM (2007) Therapeutic vaccination for HPV induced cervical cancers. Dis Markers 23:337\u2013352","journal-title":"Dis Markers"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1053\/j.gastro.2008.05.031","volume":"135","author":"EH Buster","year":"2008","unstructured":"Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, So TM, Feinman SV, Mach T, Akarca US, Schutten M, Tielemans W, van Vuuren AJ, Hansen BE, Janssen HL (2008) Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology 135:459\u2013467","journal-title":"Gastroenterology"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0168-8278(01)00005-8","volume":"34","author":"C Camm\u00e1","year":"2001","unstructured":"Camm\u00e1 C, Giunta M, Andreone P, Craxi A (2001) Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol 34:593\u2013602","journal-title":"J Hepatol"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/jnci\/djp332","volume":"101","author":"JJ Carter","year":"2009","unstructured":"Carter JJ, Paulson KG, Wipf GC, Miranda D, Madeleine MM, Johnson LG, Lemos BD, Lee S, Warcola AH, Iyer JG, Nghiem P, Galloway DA (2009) Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 101:1510\u20131522","journal-title":"J Natl Cancer Inst"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-med-050409-103711","volume":"62","author":"C Casper","year":"2011","unstructured":"Casper C (2011) The increasing burden of HIV-associated malignancies in resource-limited regions. Annu Rev Med 62:157\u2013170","journal-title":"Annu Rev Med"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","volume":"354","author":"TT Chang","year":"2006","unstructured":"Chang TT, Gish RG, de Man R, Gadano A, Sollano J, Chao YC, Lok AS, Hamn KH, Goodman Z, Zho J, Cross A, DeHertogh D, Wilber R, Colonno R, Apelian D, Group tBAS (2006) A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 354: 1001\u20131010","journal-title":"N Engl J Med"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/jnci\/djp288","volume":"101","author":"MH Chang","year":"2009","unstructured":"Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Chu HC, Wu TC, Yang SS, Kuo HS, Chen DS (2009) Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 101:1348\u20131355","journal-title":"J Natl Cancer Inst"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1002\/hep.22884","volume":"49","author":"CJ Chen","year":"2009","unstructured":"Chen CJ, Yang HI, Iloeje UH (2009) Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 49:S72\u2013S84","journal-title":"Hepatology"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ijc.1430","volume":"94","author":"D Chua","year":"2001","unstructured":"Chua D, Huang J, Zheng B, Lau SY, Luk W, Kwong DL, Sham JS, Moss D, Yuen KY, Im SW, Ng MH (2001) Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma. Int J Cancer 94:73\u201380","journal-title":"Int J Cancer"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"8942","DOI":"10.1200\/JCO.2005.02.6195","volume":"23","author":"P Comoli","year":"2005","unstructured":"Comoli P, Pedrazzoli P, Maccario R, Basso S, Carminati O, Labirio M, Schiavo R, Secondino S, Frasson C, Perotti C, Moroni M, Locatelli F, Siena S (2005) Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes. J Clin Oncol 23:8942\u20138949","journal-title":"J Clin Oncol"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00432-007-0281-2","volume":"133","author":"P Paoli De","year":"2007","unstructured":"De Paoli P, Pratesi C, Bortolin MT (2007) The Epstein Barr virus DNA levels as a tumor marker in EBV-associated cancers. J Cancer Res Clin Oncol 133:809\u2013815","journal-title":"J Cancer Res Clin Oncol"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.1840400418","volume":"40","author":"V Marco Di","year":"2004","unstructured":"Di Marco V, Marzano A, Lampertico P, Andreone P, Santantonio T, Almasio PL, Rizzetto M, Craxi A (2004) Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine. Hepatology 40:883\u2013891","journal-title":"Hepatology"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1002\/hep.22920","volume":"49","author":"JL Dienstag","year":"2009","unstructured":"Dienstag JL (2009) Benefits and risks of nucleoside analog therapy for hepatitis B. Hepatology 49:S112\u2013S121","journal-title":"Hepatology"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.antiviral.2011.05.014","volume":"91","author":"TG Edwards","year":"2011","unstructured":"Edwards TG, Koeller KJ, Slomczynska U, Fok K, Helmus M, Bashkin JK, Fisher C (2011) HPV episome levels are potently decreased by pyrrole-imidazole polyamides. Antiviral Res 91:177\u2013186","journal-title":"Antiviral Res"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264\u20131273.e1","journal-title":"Gastroenterology"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/(SICI)1097-0215(19990611)81:6<859::AID-IJC4>3.0.CO;2-K","volume":"81","author":"KI Etoh","year":"1999","unstructured":"Etoh KI, Yamaguchi K, Tokudome S, Watanabe T, Okayama A, Stuver S, Mueller N, Takatsuki K, Matsuoka M (1999) Rapid quantification of HTLV-1 provirus load: detection of monoclonal proliferation of HTLV-1-infected cells among blood donors. Int J Cancer 81:859\u2013864","journal-title":"Int J Cancer"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00001622-200109000-00008","volume":"13","author":"DV Faller","year":"2001","unstructured":"Faller DV, Mentzer SJ, Perrine SP (2001) Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies. Curr Opin Oncol 13:360\u2013367","journal-title":"Curr Opin Oncol"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/S0168-8278(03)00416-1","volume":"39","author":"CT Fang","year":"2003","unstructured":"Fang CT, Chen PJ, Chen MY, Hung CC, Chang SC, Chang AL, Chen DS (2003) Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection. J Hepatol 39:1028\u20131035","journal-title":"J Hepatol"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1002\/hep.22977","volume":"49","author":"JJ Feld","year":"2009","unstructured":"Feld JJ, Wong DK, Heathcote EJ (2009) Endpoints of therapy in chronic hepatitis B. Hepatology 49:S96\u2013S102","journal-title":"Hepatology"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1126\/science.1152586","volume":"319","author":"H Feng","year":"2008","unstructured":"Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096\u20131100","journal-title":"Science"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/QCO.0b013e3283486d04","volume":"24","author":"S Gantt","year":"2011","unstructured":"Gantt S, Casper C (2011) Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. Curr Opin Infect Dis 24:295\u2013301","journal-title":"Curr Opin Infect Dis"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"509296","DOI":"10.1155\/2012\/509296","volume":"2012","author":"SK Ghosh","year":"2012","unstructured":"Ghosh SK, Perrine SP, Faller DV (2012) Advances in virus-directed therapeutics against Epstein-Barr virus-associated malignancies. Adv Virol 2012:509296","journal-title":"Adv Virol"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","volume":"332","author":"PS Gill","year":"1995","unstructured":"Gill PS, Harrington W Jr, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S, Kornblau S, Pike MC, Levine AM (1995) Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 332:1744\u20131748","journal-title":"N Engl J Med"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00262-006-0247-2","volume":"56","author":"JG Gomez-Gutierrez","year":"2007","unstructured":"Gomez-Gutierrez JG, Elpek KG, Montes de Oca-Luna R, Shirwan H, Sam Zhou H, McMasters KM (2007) Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice. Cancer Immunol Immunother 56:997\u20131007","journal-title":"Cancer Immunol Immunother"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1128\/CMR.00063-09","volume":"23","author":"DU Goncalves","year":"2010","unstructured":"Goncalves DU, Proietti FA, Ribas JG, Araujo MG, Pinheiro SR, Guedes AC, Carneiro-Proietti AB (2010) Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev 23:577\u2013589","journal-title":"Clin Microbiol Rev"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/ijc.23012","volume":"121","author":"PE Gravitt","year":"2007","unstructured":"Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Rodriguez AC, Burk RD (2007) High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 121:2787\u20132793","journal-title":"Int J Cancer"},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood.V95.3.807.003k24_807_814","volume":"95","author":"\u00c5 Gustafsson","year":"2000","unstructured":"Gustafsson \u00c5, Levitsky V, Zou JZ, Frisan T, Dalianis T, Ljungman P, Ringden O, Winiarski J, Ernberg I, Masucci MG (2000) Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood 95:807\u2013814","journal-title":"Blood"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","volume":"332","author":"O Hermine","year":"1995","unstructured":"Hermine O, Bouscary D, Gessain A, Turlure P, Leblond V, Franck N, Buzyn-Veil A, Rio B, Macintyre E, Dreyfus F, Bazarbachi A (1995) Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 332:1749\u20131751","journal-title":"N Engl J Med"},{"key":"14_CR39","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/sj.thj.6200195","volume":"3","author":"O Hermine","year":"2002","unstructured":"Hermine O, Allard I, L\u00e9vy V, Arnulf B, Gessain A, Bazarbachi A (2002) A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma. Hematol J 3:276\u2013282","journal-title":"Hematol J"},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/sj.thj.6200374","volume":"5","author":"O Hermine","year":"2004","unstructured":"Hermine O, Dombret H, Poupon J, Arnulf B, Lefrere F, Rousselot P, Damaj G, Delarue R, Fermand JP, Brouet JC, Degos L, Varet B, de The H, Bazarbachi A (2004) Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma. Hematol J 5:130\u2013134","journal-title":"Hematol J"},{"key":"14_CR41","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","volume":"115","author":"HE Heslop","year":"2010","unstructured":"Heslop HE, Slobod KS, Pule MA, Hale GA, Rousseau A, Smith CA, Bollard CM, Liu H, Wu MF, Rochester RJ, Amrolia PJ, Hurwitz JL, Brenner MK, Rooney CM (2010) Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 115:925\u2013935","journal-title":"Blood"},{"key":"14_CR42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrgastro.2011.49","volume":"8","author":"WP Hofmann","year":"2011","unstructured":"Hofmann WP, Zeuzem S (2011) A new standard of care for the treatment of chronic HCV infection. Nat Rev Gastroenterol Hepatol 8:257\u2013264","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"14_CR43","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1478-3231.2012.02796.x","volume":"32","author":"P Ingiliz","year":"2012","unstructured":"Ingiliz P, Rockstroh JK (2012) HIV-HCV co-infection facing HCV protease inhibitor licensing: implications for clinicians. Liver Int 32:1194\u20131199","journal-title":"Liver Int"},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1038\/sj.onc.1206548","volume":"22","author":"BF Israel","year":"2003","unstructured":"Israel BF, Kenney SC (2003) Virally targeted therapies for EBV-associated malignancies. Oncogene 22:5122\u20135130","journal-title":"Oncogene"},{"key":"14_CR45","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, Ogata M, Kikuchi H, Sagara Y, Uozumi K, Mochizuki M, Tsukasaki K, Saburi Y, Yamamura M, Tanaka J, Moriuchi Y, Hino S, Kamihira S, Yamaguchi K (2010) Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 116:1211\u20131219","journal-title":"Blood"},{"key":"14_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","volume":"365","author":"HLA Janssen","year":"2005","unstructured":"Janssen HLA, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TMK, Gerken G, de Man RA, Niesters HGM, Zondervan P, Hansen B, Schalm SW (2005) Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365:123\u2013129","journal-title":"Lancet"},{"key":"14_CR47","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/COH.0b013e32834bcbd9","volume":"6","author":"M Jones","year":"2011","unstructured":"Jones M, Nunez M (2011) HIV and hepatitis C co-infection: the role of HAART in HIV\/hepatitis C virus management. Curr Opin HIV AIDS 6:546\u2013552","journal-title":"Curr Opin HIV AIDS"},{"key":"14_CR48","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ygyno.2008.06.033","volume":"111","author":"AL Jonson","year":"2008","unstructured":"Jonson AL, Rogers LM, Ramakrishnan S, Downs LS Jr (2008) Gene silencing with siRNA targeting E6\/E7 as a therapeutic intervention in a mouse model of cervical cancer. Gynecol Oncol 111:356\u2013364","journal-title":"Gynecol Oncol"},{"key":"14_CR49","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/S0140-6736(00)02401-6","volume":"355","author":"AM Josefsson","year":"2000","unstructured":"Josefsson AM, Magnusson PKE, Ylitalo N, S\u00f8rensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami H-O, Gyllensten UB (2000) Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355:2189\u20132193","journal-title":"Lancet"},{"key":"14_CR50","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/10428190601071717","volume":"48","author":"G Kchour","year":"2007","unstructured":"Kchour G, Makhoul NJ, Mahmoudi M, Kooshyar MM, Shirdel A, Rastin M, Rafatpanah H, Tarhini M, Zalloua PA, Hermine O, Farid R, Bazarbachi A (2007) Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran. Leuk Lymphoma 48:330\u2013336","journal-title":"Leuk Lymphoma"},{"key":"14_CR51","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1182\/blood-2009-03-211821","volume":"113","author":"G Kchour","year":"2009","unstructured":"Kchour G, Tarhini M, Kooshyar MM, El Hajj H, Wattel E, Mahmoudi M, Hatoum H, Rahimi H, Maleki M, Rafatpanah H, Rezaee SA, Yazdi MT, Shirdel A, de The H, Hermine O, Farid R, Bazarbachi A (2009) Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia\/lymphoma (ATL). Blood 113:6528\u20136532","journal-title":"Blood"},{"key":"14_CR52","doi-asserted-by":"publisher","first-page":"e1000363","DOI":"10.1371\/journal.ppat.1000363","volume":"5","author":"JM Kean","year":"2009","unstructured":"Kean JM, Rao S, Wang M, Garcea RL (2009) Seroepidemiology of human polyomaviruses. PLoS Pathog 5:e1000363","journal-title":"PLoS Pathog"},{"issue":"Suppl","key":"14_CR53","first-page":"238A","volume":"46","author":"WR Kim","year":"2007","unstructured":"Kim WR, Benson JT, Hindman A, Brosgart C, Fortner-Burton C (2007) Decline in the need for liver transplantation for end stage liver disease secondary to hepatitis B in the US [Abstract]. Hepatology 46(Suppl):238A","journal-title":"Hepatology"},{"key":"14_CR54","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/rmv.582","volume":"18","author":"H Kimura","year":"2008","unstructured":"Kimura H, Ito Y, Suzuki R, Nishiyama Y (2008) Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol 18:305\u2013319","journal-title":"Rev Med Virol"},{"key":"14_CR55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/mol.105.011189","volume":"68","author":"R Koivusalo","year":"2005","unstructured":"Koivusalo R, Krausz E, Helenius H, Hietanen S (2005) Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs. Mol Pharmacol 68:372\u2013382","journal-title":"Mol Pharmacol"},{"key":"14_CR56","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1080\/07357900701816477","volume":"26","author":"K Krasagakis","year":"2008","unstructured":"Krasagakis K, Kruger-Krasagakis S, Tzanakakis GN, Darivianaki K, Stathopoulos EN, Tosca AD (2008) Interferon-alpha inhibits proliferation and induces apoptosis of merkel cell carcinoma in vitro. Cancer Invest 26:562\u2013568","journal-title":"Cancer Invest"},{"key":"14_CR57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","volume":"1","author":"JL Kutok","year":"2006","unstructured":"Kutok JL, Wang F (2006) Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol Mech Dis 1:375\u2013404","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"Suppl 1","key":"14_CR58","doi-asserted-by":"publisher","first-page":"i47","DOI":"10.1136\/gutjnl-2012-302062","volume":"61","author":"K Lacombe","year":"2012","unstructured":"Lacombe K, Rockstroh J (2012) HIV and viral hepatitis coinfections: advances and challenges. Gut 61(Suppl 1):i47\u2013i58","journal-title":"Gut"},{"key":"14_CR59","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa051287","volume":"354","author":"CL Lai","year":"2006","unstructured":"Lai CL, Shouval D, Lok AS, Chang TT, Cheinquer H, Goodman Z, DeHertogh D, Wilber R, Zink RC, Cross A, Colonno R, Fernandes L, Group tBAS (2006) Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 354:1011\u20131020","journal-title":"N Engl J Med"},{"key":"14_CR60","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1056\/NEJMoa066422","volume":"357","author":"CL Lai","year":"2007","unstructured":"Lai CL, Gane E, Liaw YF, Hsu CW, Thongsawat S, Wang Y, Chen Y, Heathcote EJ, Rasenack J, Bzowej B, Naoumov NV, Di Bisceglie AM, Zeuzem S, Moon YM, Goodman Z, Chao G, Constance BF, Brown NA, Group tGS (2007) Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med 357:2576\u20132588","journal-title":"N Engl J Med"},{"key":"14_CR61","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa043470","volume":"352","author":"GKK Lau","year":"2005","unstructured":"Lau GKK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, Gane E, Fried MW, Chow WC, Paik SW, Chang WY, Berg T, Flisiak R, McCloud P, Pluck N, Group tPA-aH-PCHBS (2005) Peginterferon alfa-2a, lamivudine, and combination for HBeAg-positive chronic hepatitis B. N Engl J Med 352:2682\u20132695","journal-title":"N Engl J Med"},{"key":"14_CR62","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/135965350601100614","volume":"11","author":"YF Liaw","year":"2006","unstructured":"Liaw YF (2006) Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy. Antivir Ther 11:669\u2013679","journal-title":"Antivir Ther"},{"key":"14_CR63","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J, Group CALMS (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351:1521\u20131531","journal-title":"N Engl J Med"},{"key":"14_CR64","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2008.10.049","volume":"136","author":"CJ Liu","year":"2009","unstructured":"Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, Liao LY, Chen CL, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Liu CH, Su WW, Lin CL, Jeng YM, Chen PJ, Chen DS (2009) Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 136:496\u2013504.e3","journal-title":"Gastroenterology"},{"key":"14_CR65","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/CJI.0b013e3181f3cbf4","volume":"33","author":"CU Louis","year":"2010","unstructured":"Louis CU, Straathof K, Bollard CM, Ennamuri S, Gerken C, Lopez TT, Huls MH, Sheehan A, Wu MF, Liu H, Gee A, Brenner MK, Rooney CM, Heslop HE, Gottschalk S (2010) Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. J Immunother 33:983\u2013990","journal-title":"J Immunother"},{"key":"14_CR66","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1002\/ijc.24737","volume":"126","author":"M Loyo","year":"2010","unstructured":"Loyo M, Guerrero-Preston R, Brait M, Hoque MO, Chuang A, Kim MS, Sharma R, Liegeois NJ, Koch WM, Califano JA, Westra WH, Sidransky D (2010) Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int J Cancer 126:2991\u20132996","journal-title":"Int J Cancer"},{"key":"14_CR67","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1086\/315088","volume":"180","author":"A Manns","year":"1999","unstructured":"Manns A, Miley WJ, Wilks RJ, Morgan OSC, Hanchard B, Wharfe G, Caranston B, Maloney W, Welles SL, Blattner WA, Waters D (1999) Quantitative proviral DNA and antibody levels in the natural history of HTLV-1 infection. J Infect Dis 180:1487\u20131493","journal-title":"J Infect Dis"},{"key":"14_CR68","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa040431","volume":"351","author":"P Marcellin","year":"2004","unstructured":"Marcellin P, Lau GKK, Bonino F, Farci P, Hadziyannis S, Jin R, Lu ZM, Piratvisuth T, Germanidis G, Yurdaydin C, Diago M, Gurel S, Lai MY, Button P, Pluck N, Group tPA-aH-NCHBS (2004) Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med 351:1206\u20131217","journal-title":"N Engl J Med"},{"key":"14_CR69","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","volume":"359","author":"P Marcellin","year":"2008","unstructured":"Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F (2008) Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 359:2442\u20132455","journal-title":"N Engl J Med"},{"key":"14_CR70","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2009.03.006","volume":"136","author":"P Marcellin","year":"2009","unstructured":"Marcellin P, Bonino F, Lau GK, Farci P, Yurdaydin C, Piratvisuth T, Jin R, Gurel S, Lu ZM, Wu J, Popescu M, Hadziyannis S (2009) Sustained response of hepatitis B e antigen-negative patients 3\u00a0years after treatment with peginterferon alpha-2a. Gastroenterology 136:2169\u20132179.e1\u2013e4","journal-title":"Gastroenterology"},{"key":"14_CR71","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1586\/eri.11.10","volume":"9","author":"M Masarone","year":"2011","unstructured":"Masarone M, Persico M (2011) Antiviral therapy: why does it fail in HCV-related chronic hepatitis? Expert Rev Anti Infect 9:535\u2013543","journal-title":"Expert Rev Anti Infect"},{"issue":"Suppl 1","key":"14_CR72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000315225","volume":"78","author":"R Masuzaki","year":"2010","unstructured":"Masuzaki R, Yoshida H, Omata M (2010) Interferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis\/liver cirrhosis. Oncology 78(Suppl 1):17\u201323","journal-title":"Oncology"},{"key":"14_CR73","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1046\/j.1365-2141.2001.02794.x","volume":"113","author":"E Matutes","year":"2001","unstructured":"Matutes E, Taylor GP, Cavenagh J, Pagliuca A, Bareford D, Domingo A, Hamblin M, Kelsey S, Mir N, Reilly JT (2001) Interferon \u03b1 and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients. Br J Haematol 113:779\u2013784","journal-title":"Br J Haematol"},{"key":"14_CR74","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12185-011-0782-2","volume":"93","author":"A Merlo","year":"2011","unstructured":"Merlo A, Turrini R, Dolcetti R, Zanovello P, Rosato A (2011) Immunotherapy for EBV-associated malignancies. Int J Hematol 93:281\u2013293","journal-title":"Int J Hematol"},{"key":"14_CR75","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrc2888","volume":"10","author":"EA Mesri","year":"2010","unstructured":"Mesri EA, Cesarman E, Boshoff C (2010) Kaposi\u2019s sarcoma and its associated herpesvirus. Nat Rev Cancer 10:707\u2013719","journal-title":"Nat Rev Cancer"},{"key":"14_CR76","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1053\/jhep.2003.50208","volume":"37","author":"H Mommeja-Marin","year":"2003","unstructured":"Mommeja-Marin H, Mondou E, Blum MR, Rousseau F (2003) Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37:1309\u20131319","journal-title":"Hepatology"},{"key":"14_CR77","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/QAD.0b013e3283262a8d","volume":"23","author":"P Monini","year":"2009","unstructured":"Monini P, Sgadari C, Garosso MG, Bellino S, Biagio AD, Toschi E, Bacigalupo S, Sabbatucci M, Cencioni G, Salvi E, Leone P, Ensoli B, Sarcoma tCAoKs (2009) Clinical course of classic Kaposi\u2019s sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir. AIDS 23:534\u2013538","journal-title":"AIDS"},{"key":"14_CR78","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/nrc2961","volume":"10","author":"PS Moore","year":"2010","unstructured":"Moore PS, Chang Y (2010) Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 10:878\u2013889","journal-title":"Nat Rev Cancer"},{"key":"14_CR79","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1743-422X-7-296","volume":"7","author":"S Munir","year":"2010","unstructured":"Munir S, Saleem S, Idrees M, Tariq A, Butt S, Rauff B, Hussain A, Badar S, Naudhani M, Fatima Z, Ali M, Ali L, Akram M, Aftab M, Khubaib B, Awan Z (2010) Hepatitis C treatment: current and future perspectives. Virol J 7:296","journal-title":"Virol J"},{"key":"14_CR80","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jdermsci.2009.07.013","volume":"56","author":"H Nakajima","year":"2009","unstructured":"Nakajima H, Takaishi M, Yamamoto M, Kamijima R, Kodama H, Tarutani M, Sano S (2009) Screening of the specific polyoma virus as diagnostic and prognostic tools for Merkel cell carcinoma. J Dermatol Sci 56:211\u2013213","journal-title":"J Dermatol Sci"},{"key":"14_CR81","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/QAD.0b013e3282ff6275","volume":"22","author":"HQ Nguyen","year":"2008","unstructured":"Nguyen HQ, Magaret AS, Kitahata MM, van Rompaey SE, Wald A, Casper C (2008) Persistent Kaposi sarcoma in era of highly active antiretroviral therapy: characterizing the predictors of clinical response. AIDS 22:937\u2013945","journal-title":"AIDS"},{"key":"14_CR82","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1056\/NEJM199605303342202","volume":"334","author":"C Niederau","year":"1996","unstructured":"Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, H\u00e4ussinger D (1996) Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 334:1422\u20131427","journal-title":"N Engl J Med"},{"key":"14_CR83","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.20144","volume":"110","author":"A Okayama","year":"2004","unstructured":"Okayama A, Stuver S, Matsuoka M, Ishizaki J, Tanaka G, Kubuki Y, Mueller N, Hsieh CC, Tachibana N, Tsubouchi H (2004) Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia\/lymphoma in asymptomatic carriers. Int J Cancer 110:621\u2013625","journal-title":"Int J Cancer"},{"key":"14_CR84","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1046\/j.1365-2036.2001.00979.x","volume":"15","author":"GV Papatheodoridis","year":"2001","unstructured":"Papatheodoridis GV, Papatheodoridis VC, Hadziyannis SJ (2001) Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis. Aliment Pharmacol Ther 15:689\u2013698","journal-title":"Aliment Pharmacol Ther"},{"key":"14_CR85","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1473-3099(07)70264-5","volume":"8","author":"GV Papatheodoridis","year":"2008","unstructured":"Papatheodoridis GV, Manolakopoulos S, Dusheiko G, Archimandritis AJ (2008) Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. Lancet Infect Dis 8:167\u2013178","journal-title":"Lancet Infect Dis"},{"key":"14_CR86","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","volume":"53","author":"GV Papatheodoridis","year":"2010","unstructured":"Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A (2010) Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol 53:348\u2013356","journal-title":"J Hepatol"},{"key":"14_CR87","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","volume":"109","author":"SP Perrine","year":"2007","unstructured":"Perrine SP, Hermine O, Small T, Suarez F, O\u2019Reilly R, Boulad F, Fingeroth J, Askin M, Levy A, Mentzer SJ, Di Nicola M, Gianni AM, Klein C, Horwitz S, Faller DV (2007) A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood 109:2571\u20132578","journal-title":"Blood"},{"key":"14_CR88","first-page":"7514","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77:7514\u20137519","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR89","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1517\/14656561003637659","volume":"11","author":"A Potthoff","year":"2010","unstructured":"Potthoff A, Manns MP, Wedemeyer H (2010) Treatment of HBV\/HCV coinfection. Expert Opin Pharmacother 11:919\u2013928","journal-title":"Expert Opin Pharmacother"},{"key":"14_CR90","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24:6058\u20136068","journal-title":"Oncogene"},{"key":"14_CR91","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1124\/mol.105.014191","volume":"68","author":"LN Putral","year":"2005","unstructured":"Putral LN, Bywater MJ, Gu W, Saunders NA, Gabrielli BG, Leggatt GR, McMillan NA (2005) RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Mol Pharmacol 68:1311\u20131319","journal-title":"Mol Pharmacol"},{"key":"14_CR92","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1872-034X.2012.00984.x","volume":"42","author":"LS Qu","year":"2012","unstructured":"Qu LS, Chen H, Kuai XL, Xu ZF, Jin F, Zhou GX (2012) Effects of interferon therapy on development of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis: A meta-analysis of randomized controlled trials. Hepatol Res 42:782\u2013789","journal-title":"Hepatol Res"},{"key":"14_CR93","doi-asserted-by":"publisher","first-page":"e4420","DOI":"10.1371\/journal.pone.0004420","volume":"4","author":"L Ratner","year":"2009","unstructured":"Ratner L, Harrington W, Feng X, Grant C, Jacobson S, Noy A, Sparano J, Lee J, Ambinder R, Campbell N, Lairmore M (2009) Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. PLoS ONE 4:e4420","journal-title":"PLoS ONE"},{"key":"14_CR94","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","volume":"345","author":"CM Rooney","year":"1995","unstructured":"Rooney CM, Smith CA, Ng CYC, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9\u201313","journal-title":"Lancet"},{"key":"14_CR95","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/CCO.0b013e32834fc9fe","volume":"24","author":"D Schrama","year":"2012","unstructured":"Schrama D, Ugurel S, Becker JC (2012) Merkel cell carcinoma: recent insights and new treatment options. Curr Opin Oncol 24:141\u2013149","journal-title":"Curr Opin Oncol"},{"key":"14_CR96","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ygyno.2007.04.039","volume":"106","author":"N Sima","year":"2007","unstructured":"Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, Lu Y, Ma D (2007) Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Gynecol Oncol 106:299\u2013304","journal-title":"Gynecol Oncol"},{"key":"14_CR97","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cgh.2009.10.026","volume":"8","author":"AK Singal","year":"2010","unstructured":"Singal AK, Singh A, Jaganmohan S, Guturu P, Mummadi R, Kuo YF, Sood GK (2010) Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 8:192\u2013199","journal-title":"Clin Gastroenterol Hepatol"},{"key":"14_CR98","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.antiviral.2009.10.021","volume":"85","author":"V Soriano","year":"2010","unstructured":"Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P (2010) Viral hepatitis and HIV co-infection. Antiviral Res 85:303\u2013315","journal-title":"Antiviral Res"},{"key":"14_CR99","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1182\/blood-2004-07-2975","volume":"105","author":"KCM Straathof","year":"2005","unstructured":"Straathof KCM, Bollard CM, Popat U, Huls MH, Lopez T, Morriss MC, Gresik MV, Gee AP, Russell HV, Brenner MK, Rooney CM, Heslop HE (2005) Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes. Blood 105:1898\u20131904","journal-title":"Blood"},{"key":"14_CR100","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/j.1365-2036.2008.03816.x","volume":"28","author":"JJ Sung","year":"2008","unstructured":"Sung JJ, Tsoi KK, Wong VW, Li KC, Chan HL (2008) Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma. Aliment Pharmacol Ther 28:1067\u20131077","journal-title":"Aliment Pharmacol Ther"},{"key":"14_CR101","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11908-010-0092-5","volume":"12","author":"M Sunil","year":"2010","unstructured":"Sunil M, Reid E, Lechowicz MJ (2010) Update on HHV-8-associated malignancies. Curr Infect Dis Rep 12:147\u2013154","journal-title":"Curr Infect Dis Rep"},{"key":"14_CR102","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/ijc.24509","volume":"125","author":"YL Tolstov","year":"2009","unstructured":"Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, Chang Y, Buck CB, Moore PS (2009) Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 125:1250\u20131256","journal-title":"Int J Cancer"},{"issue":"Suppl","key":"14_CR103","first-page":"717A","volume":"48","author":"M Toy","year":"2008","unstructured":"Toy M, Veldhuijzen IK, De Man RA, Richardus J, Schalm SW (2008) The potential impact of long-term nucleoside therapy on the mortality and morbidity of high viremic chronic hepatitis B [Abstract]. Hepatology 48(Suppl):717A","journal-title":"Hepatology"},{"key":"14_CR104","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","volume":"27","author":"K Tsukasaki","year":"2009","unstructured":"Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, O\u2019Mahony D, Janik JE, Bittencourt AL, Taylor GP, Yamaguchi K, Utsunomiya A, Tobinai K, Watanabe T (2009) Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27:453\u2013459","journal-title":"J Clin Oncol"},{"key":"14_CR105","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/hep.20128","volume":"39","author":"M Zonneveld van","year":"2004","unstructured":"van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL (2004) Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. Hepatology 39:804\u2013810","journal-title":"Hepatology"},{"key":"14_CR106","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1158\/0008-5472.CAN-11-2651","volume":"72","author":"C Willmes","year":"2012","unstructured":"Willmes C, Adam C, Alb M, Volkert L, Houben R, Becker JC, Schrama D (2012) Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens. Cancer Res 72:2120\u20132128","journal-title":"Cancer Res"},{"key":"14_CR107","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1365-2036.2010.04447.x","volume":"32","author":"GL Wong","year":"2010","unstructured":"Wong GL, Yiu KK, Wong VW, Tsoi KK, Chan HL (2010) Meta-analysis: reduction in hepatic events following interferon-alfa therapy of chronic hepatitis B. Aliment Pharmacol Ther 32:1059\u20131068","journal-title":"Aliment Pharmacol Ther"},{"key":"14_CR108","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc2050","volume":"7","author":"CB Woodman","year":"2007","unstructured":"Woodman CB, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7:11\u201322","journal-title":"Nat Rev Cancer"},{"key":"14_CR109","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/infdis\/jir049","volume":"203","author":"LF Xi","year":"2011","unstructured":"Xi LF, Hughes JP, Castle PE, Edelstein ZR, Wang C, Galloway DA, Koutsky LA, Kiviat NB, Schiffman M (2011) Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study. J Infect Dis 203:1425\u20131433","journal-title":"J Infect Dis"},{"key":"14_CR110","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2893.2009.01070.x","volume":"16","author":"YF Yang","year":"2009","unstructured":"Yang YF, Zhao W, Zhong YD, Xia HM, Shen L, Zhang N (2009) Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis. J Viral Hepat 16:265\u2013271","journal-title":"J Viral Hepat"},{"key":"14_CR111","doi-asserted-by":"publisher","first-page":"e20752","DOI":"10.1371\/journal.pone.0020752","volume":"6","author":"ML Yeh","year":"2011","unstructured":"Yeh ML, Hung CH, Huang JF, Liu CJ, Lee CM, Dai CY, Wang JH, Lin ZY, Lu SN, Hu TH, Yu ML, Kao JH, Chuang WL, Chen PJ, Chen DS (2011) Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses. PLoS ONE 6:e20752","journal-title":"PLoS ONE"},{"key":"14_CR112","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/ijc.25767","volume":"129","author":"CH Zhang","year":"2011","unstructured":"Zhang CH, Xu GL, Jia WD, Li JS, Ma JL, Ge YS (2011) Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials. Int J Cancer 129:1254\u20131264","journal-title":"Int J Cancer"},{"key":"14_CR113","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ygyno.2011.10.028","volume":"124","author":"J Zhou","year":"2012","unstructured":"Zhou J, Peng C, Li B, Wang F, Zhou C, Hong D, Ye F, Cheng X, Lu W, Xie X (2012) Transcriptional gene silencing of HPV16 E6\/E7 induces growth inhibition via apoptosis in vitro and in vivo. Gynecol Oncol 124:296\u2013302","journal-title":"Gynecol Oncol"},{"key":"14_CR114","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4049\/jimmunol.169.1.350","volume":"169","author":"S Zwaveling","year":"2002","unstructured":"Zwaveling S, Ferreira Mota SC, Nouta J, Johnson M, Lipford GB, Offringa R, van der Burg SH, Melief CJM (2002) Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J Immunol 169:350\u2013358","journal-title":"J Immunol"}],"container-title":["Recent Results in Cancer Research","Viruses and Human Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-38965-8_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T17:11:59Z","timestamp":1715965919000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-38965-8_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,6]]},"ISBN":["9783642389641","9783642389658"],"references-count":114,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-38965-8_14","relation":{},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,6]]}}}